207 related articles for article (PubMed ID: 12472667)
1. CD40, CD154, Bax and Bcl-2 expression in Sjögren's syndrome salivary glands: a putative anti-apoptotic role during its effector phases.
Ohlsson M; Szodoray P; Loro LL; Johannessen AC; Jonsson R
Scand J Immunol; 2002 Dec; 56(6):561-71. PubMed ID: 12472667
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome.
Nakamura H; Kawakami A; Tominaga M; Migita K; Kawabe Y; Nakamura T; Eguchi K
Lab Invest; 1999 Mar; 79(3):261-9. PubMed ID: 10092062
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 family expression in salivary glands from patients with primary Sjögren's syndrome: involvement of Bax in salivary gland destruction.
Kong L; Ogawa N; McGuff HS; Nakabayashi T; Sakata KM; Masago R; Vela-Roch N; Talal N; Dang H
Clin Immunol Immunopathol; 1998 Aug; 88(2):133-41. PubMed ID: 9714690
[TBL] [Abstract][Full Text] [Related]
4. Modes of epithelial cell death and repair in Sjögren's syndrome (SS).
Polihronis M; Tapinos NI; Theocharis SE; Economou A; Kittas C; Moutsopoulos HM
Clin Exp Immunol; 1998 Dec; 114(3):485-90. PubMed ID: 9844061
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of apoptosis and bcl-2 in Sjögren's syndrome.
Manganelli P; Quaini F; Andreoli AM; Lagrasta C; Pilato FP; Zuccarelli A; Monteverdi R; D'Aversa C; Olivetti G
J Rheumatol; 1997 Aug; 24(8):1552-7. PubMed ID: 9263150
[TBL] [Abstract][Full Text] [Related]
6. [Molecular mechanisms of salivary gland destruction in patients with Sjogren's syndrome. ].
Ogawa N; Shimoyama K; Kawanami T
Nihon Rinsho Meneki Gakkai Kaishi; 2005 Feb; 28(1):10-20. PubMed ID: 15744117
[TBL] [Abstract][Full Text] [Related]
7. CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation.
Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
Clin Exp Immunol; 2002 Feb; 127(2):386-92. PubMed ID: 11876766
[TBL] [Abstract][Full Text] [Related]
8. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome.
Kong L; Ogawa N; Nakabayashi T; Liu GT; D'Souza E; McGuff HS; Guerrero D; Talal N; Dang H
Arthritis Rheum; 1997 Jan; 40(1):87-97. PubMed ID: 9008604
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis in labial salivary glands from Sjögren's syndrome (SS) patients: comparison with human T lymphotropic virus-I (HTLV-I)-seronegative and -seropositive SS patients.
Nakamura H; Koji T; Tominaga M; Kawakami A; Migita K; Kawabe Y; Nakamura T; Shirabe S; Eguchi K
Clin Exp Immunol; 1998 Oct; 114(1):106-12. PubMed ID: 9764611
[TBL] [Abstract][Full Text] [Related]
10. [Apoptosis and related gene expression in lacrimal gland of cases with Sjögren's syndrome].
Wu J; Fei P; Gong Y; Zhao J; Dong J; Tang F
Zhonghua Yan Ke Za Zhi; 2000 Jul; 36(4):255-8, 14. PubMed ID: 11853607
[TBL] [Abstract][Full Text] [Related]
11. Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren's syndrome.
Ping L; Ogawa N; Sugai S
Arthritis Rheum; 2005 Feb; 52(2):573-81. PubMed ID: 15692983
[TBL] [Abstract][Full Text] [Related]
12. [Study of apoptosis in Sjögren's syndrome].
Ogawa N; Ohashi H
Rinsho Byori; 1997 Jul; 45(7):643-8. PubMed ID: 9256010
[TBL] [Abstract][Full Text] [Related]
13. Local administration of soluble CD40:Fc to the salivary glands of non-obese diabetic mice does not ameliorate autoimmune inflammation.
Roescher N; Vosters JL; Lai Z; Uede T; Tak PP; Chiorini JA
PLoS One; 2012; 7(12):e51375. PubMed ID: 23300544
[TBL] [Abstract][Full Text] [Related]
14. Adipose tissue is prominent in salivary glands of Sjögren's syndrome patients and appears to influence the microenvironment in these organs.
Skarstein K; Aqrawi LA; Øijordsbakken G; Jonsson R; Jensen JL
Autoimmunity; 2016 Aug; 49(5):338-46. PubMed ID: 27206986
[TBL] [Abstract][Full Text] [Related]
15. Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome.
Wieczorek G; Bigaud M; Pfister S; Ceci M; McMichael K; Afatsawo C; Hamburger M; Texier C; Henry M; Cojean C; Erard M; Mamber N; Rush JS
Ann Rheum Dis; 2019 Jul; 78(7):974-978. PubMed ID: 30902822
[TBL] [Abstract][Full Text] [Related]
16. Investigation of activation markers demonstrates significant overexpression of the secretory component on salivary glands epithelial cells in Sjögren's syndrome.
El Kaissouni J; Bene MC; Faure GC
Clin Immunol Immunopathol; 1996 Jun; 79(3):236-43. PubMed ID: 8635281
[TBL] [Abstract][Full Text] [Related]
17. Elevated proapoptotic Bax and caspase 3 activation in the NOD.scid model of Sjögren's syndrome.
Masago R; Aiba-Masago S; Talal N; Zuluaga FJ; Al-Hashimi I; Moody M; Lau CA; Peck AB; Brayer J; Humphreys-Beher MG; Dang H
Arthritis Rheum; 2001 Mar; 44(3):693-702. PubMed ID: 11263785
[TBL] [Abstract][Full Text] [Related]
18. Fas-induced apoptosis is a rare event in Sjögren's syndrome.
Ohlsson M; Skarstein K; Bolstad AI; Johannessen AC; Jonsson R
Lab Invest; 2001 Jan; 81(1):95-105. PubMed ID: 11204278
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of X chromosome-linked inhibitor of apoptosis protein in Sjögren's syndrome.
Nakamura H; Kawakami A; Yamasaki S; Nakashima T; Kamachi M; Migita K; Kawabe Y; Nakamura T; Koji T; Hayashi Y; Eguchi K
Lab Invest; 2000 Sep; 80(9):1421-7. PubMed ID: 11005210
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and Sjögren syndrome.
Manganelli P; Fietta P
Semin Arthritis Rheum; 2003 Aug; 33(1):49-65. PubMed ID: 12920696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
